Literature DB >> 17443224

Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas.

B Falini, D Lenze, R Hasserjian, S Coupland, D Jaehne, C Soupir, A Liso, M P Martelli, N Bolli, F Bacci, V Pettirossi, A Santucci, M F Martelli, S Pileri, H Stein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17443224     DOI： 10.1038/sj.leu.2404699

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  32 in total

1.  Molecular and alternative methods for diagnosis of acute myeloid leukemia with mutated NPM1: flexibility may help.

Authors:  Brunangelo Falini; Maria Paola Martelli; Stefano A Pileri; Cristina Mecucci
Journal:  Haematologica       Date:  2010-04       Impact factor: 9.941

2.  A single center analysis of nucleophosmin in acute myeloid leukemia: value of combining immunohistochemistry with molecular mutation analysis.

Authors:  Carolien M Woolthuis; André B Mulder; Rikst Nynke Verkaik-Schakel; Stefano Rosati; Arjan Diepstra; Eva van den Berg; Jan Jacob Schuringa; Edo Vellenga; Philip M Kluin; Gerwin Huls
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

Review 3.  Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity.

Authors:  Rachel Rau; Patrick Brown
Journal:  Hematol Oncol       Date:  2009-12       Impact factor: 5.271

4.  Allogeneic hematopoietic stem cell transplantation for isolated and leukemic myeloid sarcoma in adults: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation.

Authors:  Patrice Chevallier; Myriam Labopin; Jan Cornelissen; Gérard Socié; Vanderson Rocha; Mohamad Mohty
Journal:  Haematologica       Date:  2011-06-17       Impact factor: 9.941

5.  ¹⁸F-FDG-PET/CT for detection of extramedullary acute myeloid leukemia.

Authors:  Friedrich Stölzel; Christoph Röllig; Jörgen Radke; Brigitte Mohr; Uwe Platzbecker; Martin Bornhäuser; Tobias Paulus; Gerhard Ehninger; Klaus Zöphel; Markus Schaich
Journal:  Haematologica       Date:  2011-06-17       Impact factor: 9.941

6.  NPM1 mutation is associated with leukemia cutis in acute myeloid leukemia with monocytic features.

Authors:  Marlise R Luskin; Auris O Huen; Sarah A Brooks; Campbell Stewart; Christopher D Watt; Jennifer J D Morrissette; David B Lieberman; Adam Bagg; Misha Rosenbach; Alexander E Perl
Journal:  Haematologica       Date:  2015-06-25       Impact factor: 9.941

Review 7.  Is acute myeloid leukemia a liquid tumor?

Authors:  Maro Ohanian; Stefan Faderl; Farhad Ravandi; Naveen Pemmaraju; Guillermo Garcia-Manero; Jorge Cortes; Zeev Estrov
Journal:  Int J Cancer       Date:  2013-02-04       Impact factor: 7.396

8.  HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis.

Authors:  Yuqing Sun; Bo Zhou; Fengbiao Mao; Jing Xu; Hongzhi Miao; Zhenhua Zou; Le Tran Phuc Khoa; Younghoon Jang; Sheng Cai; Matthew Witkin; Richard Koche; Kai Ge; Gregory R Dressler; Ross L Levine; Scott A Armstrong; Yali Dou; Jay L Hess
Journal:  Cancer Cell       Date:  2018-09-27       Impact factor: 31.743

9.  Nucleophosmin, a critical Bax cofactor in ischemia-induced cell death.

Authors:  Zhiyong Wang; Jonathan M Gall; Ramon Bonegio; Andrea Havasi; Katarina Illanes; John H Schwartz; Steven C Borkan
Journal:  Mol Cell Biol       Date:  2013-03-04       Impact factor: 4.272

10.  Genomic aberrations in myeloid sarcoma without blood or bone marrow involvement: characterization of formalin-fixed paraffin-embedded samples by chromosomal microarrays.

Authors:  M Kamran Mirza; Madina Sukhanova; Friedrich Stölzel; Kenan Onel; Richard A Larson; Wendy Stock; Gerhard Ehninger; Friederike Kuithan; Klaus Zöphel; Poluru Reddy; Loren Joseph; Gordana Raca
Journal:  Leuk Res       Date:  2014-05-21       Impact factor: 3.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.